The market for medical mobile apps is projected to reach $14 billion by 2020. This rapid, high-volume growth is being driven by the adoption of mobile computing among caregivers who want accuracy and speed in the diagnosis and treatment of medical issues. The largest market worldwide is the US followed by Asia-Pacific. Among the key drivers of this growth are expanding connectivity and the increased use of medical apps to provide care to patients locally as well as in remote locations.
On March 16, Diane Romza-Kutz will present a TCLE on "Mobile medical apps and FDA’s new cybersecurity guidance: It’s a new world.” This third webinar in the Cloud Computing Series will provide an overview of this area, define medical mobile apps, discuss when these apps are just accessories to a smartphone and when the app becomes a regulated medical device. They will also discuss Medical Device Data Systems, where data are stored and displayed.
Some of these issues and developments were explored on our Health Law Checkup blog and can be found here.
If you are engaged in the manufacture or the distribution of medical mobile apps, or a physician or staff member implementing medical mobile apps in your practices, feel free to participate in this worthwhile TCLE. Here's the link.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.